Rossmax International (ROCO:4121) PB Ratio: 0.79 (As of Jul. 26, 2026) — 22% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4121 Rossmax International Ltd ROCO:4121
60 GF Score
Price NT$13.50
GF Value NT$19.00
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Rossmax International PB Ratio?

Rossmax International ROCO:4121 -1.10% 60 PB Ratio is 0.79 as of Jul. 26, 2026, which is 22% below its 10-year median of 1.01. GuruFocus rates ROCO:4121 with a GF Score™ of 60/100 and a GF Value™ of NT$19.00 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Rossmax International ranks better than 85.03% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-26), Rossmax International's share price is NT$13.50. Rossmax International's Book Value per Share for the quarter that ended in Dec. 2025 was NT$17.04. Hence, Rossmax International's PB Ratio of today is 0.79.

Good Sign:

Rossmax International Ltd stock PB Ratio (=0.79) is close to 5-year low of 0.72.

The historical rank and industry rank for Rossmax International's PB Ratio or its related term are showing as below:

ROCO:4121' s PB Ratio Range Over the Past 10 Years
Min: 0.67   Med: 1.01   Max: 1.89
Current: 0.79

During the past 13 years, Rossmax International's highest PB Ratio was 1.89. The lowest was 0.67. And the median was 1.01.

ROCO:4121's PB Ratio is ranked better than
85.03% of 788 companies
in the Medical Devices & Instruments industry
Industry Median: 2.005 vs ROCO:4121: 0.79

During the past 12 months, Rossmax International's average Book Value Per Share Growth Rate was -1.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -2.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 1.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Rossmax International was 6.40% per year. The lowest was -2.30% per year. And the median was 0.35% per year.

Back to Basics: PB Ratio


Rossmax International  (ROCO:4121) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Rossmax International PB Ratio Related Terms


Rossmax International PB Ratio Historical Data

* Premium members only.

The historical data trend for Rossmax International's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossmax International PB Ratio Chart

Rossmax International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.23 1.34 1.47 1.01 0.92

Rossmax International Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.89 0.85 0.86 0.92

ROCO:4121 vs ABT, SYK, MDT: PB Ratio Comparison

For the Medical Devices subindustry, Rossmax International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rossmax International PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rossmax International's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rossmax International's PB Ratio falls into.


ROCO:4121
60GF Score
Rossmax International Ltd ROCO:4121
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossmax International PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Rossmax International's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=13.50/17.041
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 0.79 mean?
Rossmax International (ROCO:4121) has a PB Ratio of 0.79 as of Jul. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rossmax International and its competitors. This is 22% below median its historical median of 1.01. Over the past decade, Rossmax International's PB Ratio has ranged from 0.67 to 1.89. According to the industry distribution chart, Rossmax International ranks #118 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 15%.
Is Rossmax International's PB Ratio too high?
Rossmax International's current PB Ratio of 0.79 is 22% below median its 10-year median of 1.01. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 1.89. The Medical Devices & Instruments industry median PB Ratio is 2.01. Rossmax International's value of 0.79 is 60.6% below this industry median. Based on the distribution chart, Rossmax International ranks #118 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Rossmax International has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rossmax International's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rossmax International ranks #118 out of 788 companies for PB Ratio. This places Rossmax International in the top 15% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.01. Rossmax International's value of 0.79 is 60.6% below this benchmark. Historically, Rossmax International's own PB Ratio has ranged from 0.67 to 1.89 over the past decade. While the company's 10-year median is 1.01 vs. the industry median of 2.01, Rossmax International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.01, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossmax International's current PB Ratio of 0.79 is 60.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rossmax International and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossmax International's current PB Ratio is 0.79, which is 22% below median its own 10-year median of 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossmax International stock overvalued right now?
Based on GuruFocus' analysis, Rossmax International (ROCO:4121) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$19.00, compared to a current price of NT$13.50 — trading 28.9% below its estimated fair value. The current PB Ratio is 0.79, which is 22% below median its 10-year median of 1.01 and 60.6% below the Medical Devices & Instruments industry median of 2.01. Rossmax International's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Rossmax International (ROCO:4121), the current PB Ratio is 0.79 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossmax International (ROCO:4121) Overvalued in 2026?

Based on GuruFocus' analysis, Rossmax International stock appears to be undervalued. The current stock price of NT$13.50 is trading 28.9% below its estimated GF Value™ of NT$19.00. GuruFocus considers Rossmax International to be Modestly Undervalued.

Key valuation signals for ROCO:4121:

  • PB Ratio: 0.79 (22% below median its 10-year median of 1.01)
  • GF Value™: NT$19.00 vs. price of NT$13.50 (28.9% below fair value)
  • GF Score™: 60/100 with 5 warning signs
  • Industry Position: 60.6% below the Medical Devices & Instruments median (#118 of 788)

No single metric tells the full story. See the ROCO:4121 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rossmax International Business Description

Address Kangchien Road, 12th Floor, No. 189, Neihu District, Taipei, TWN, 114
Rossmax International Ltd is mainly engaged in medical equipment manufacturing, wholesale or retail, and the medicine and cosmetics channels. The group has three reportable departments: the medical device department, the retail channel department, and the investment department. The medical device department manufactures various types of medical supplies. The retail channel department is engaged in the retail of cosmetics, medical equipment, food products, and beverages. Geographically, it derives key revenue from the Taiwan region and the rest from Iraq, Algeria, the U.S.A, the U.A.E, Malaysia, Iran, Kazakhstan, South Korea, Norway, Croatia, Tunisia, and Other.
60GF Score

Get the complete analysis for ROCO:4121

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.50
Price
NT$19.00
GF Value